Patents by Inventor Li-fang Liang

Li-fang Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180134779
    Abstract: Methods for treating diabetes by administering an inhibitor of GDF-8, or a related member of Transforming Growth Factor-beta (TGF-?) superfamily of structurally-related growth factors (e.g., GDF-11) are disclosed. Also disclosed are methods for upregulating expression of hexose transporters, such as GLUT4 and GLUT 1, in a subject by administering an inhibitor of GDF-8. Also disclosed are methods for increasing glucose uptake by cells in a subject, by administering an inhibitor of GDF-8.
    Type: Application
    Filed: August 24, 2017
    Publication date: May 17, 2018
    Inventors: Gideon Strassmann, Li-Fang Liang, Stavros Topouzis
  • Publication number: 20160122424
    Abstract: Methods for treating diabetes by administering an inhibitor of GDF-8, or a related member of Transforming Growth Factor-beta (TGF-?) superfamily of structurally-related growth factors (e.g., GDF-11) are disclosed. Also disclosed are methods for upregulating expression of hexose transporters, such as GLUT4 and GLUT 1, in a subject by administering an inhibitor of GDF-8. Also disclosed are methods for increasing glucose uptake by cells in a subject, by administering an inhibitor of GDF-8.
    Type: Application
    Filed: August 28, 2015
    Publication date: May 5, 2016
    Inventors: Gideon STRASSMANN, Li-Fang LIANG, Stavros TOPOUZIS
  • Patent number: 9150643
    Abstract: Methods for treating diabetes by administering an inhibitor of GDF-8, or a related member of Transforming Growth Factor-beta (TGF-?) superfamily of structurally-related growth factors (e.g., GDF-11) are disclosed. Also disclosed are methods for upregulating expression of hexose transporters, such as GLUT4 and GLUT1, in a subject by administering an inhibitor of GDF-8. Also disclosed are methods for increasing glucose uptake by cells in a subject, by administering an inhibitor of GDF-8.
    Type: Grant
    Filed: February 14, 2008
    Date of Patent: October 6, 2015
    Assignee: Scidera, Inc.
    Inventors: Li-Fang Liang, Stavros Topouzis
  • Publication number: 20090035297
    Abstract: Methods for treating diabetes by administering an inhibitor of GDF-8, or a related member of Transforming Growth Factor-beta (TGF-?) superfamily of structurally-related growth factors (e.g., GDF-11) are disclosed. Also disclosed are methods for upregulating expression of hexose transporters, such as GLUT4 and GLUT1, in a subject by administering an inhibitor of GDF-8. Also disclosed are methods for increasing glucose uptake by cells in a subject, by administering an inhibitor of GDF-8.
    Type: Application
    Filed: February 14, 2008
    Publication date: February 5, 2009
    Inventors: Gideon Strassmann, Li-Fang Liang, Stavros Topouzis
  • Publication number: 20070161002
    Abstract: GDF promoters (e.g., GDF-8 promoters) are described. Also described are methods of using the GDF promoters to regulate tissue-specific gene expression, and to identify compounds which regulate GDF expression.
    Type: Application
    Filed: June 23, 2003
    Publication date: July 12, 2007
    Inventor: Li-fang Liang
  • Publication number: 20060121035
    Abstract: Methods for treating diabetes by administering an inhibitor of GDF-8, or a related member of Transforming Growth Factor-beta (TGF-?) superfamily of structurally-related growth factors (e.g., GDF-11) are disclosed. Also disclosed are methods for upregulating expression of hexose transporters, such as GLUT4 and GLUT1, in a subject by administering an inhibitor of GDF-8. Also disclosed are methods for increasing glucose uptake by cells in a subject, by administering an inhibitor of GDF-8.
    Type: Application
    Filed: June 16, 2005
    Publication date: June 8, 2006
    Inventors: Gideon Strassmann, Li-fang Liang, Stavros Topouzis
  • Patent number: 6555672
    Abstract: GDF promoters (e.g., GDF-8 promoters) are described. Also described are methods of using the GDF promoters to regulate tissue-specific gene expression, and to identify compounds which regulate GDF expression.
    Type: Grant
    Filed: July 15, 1999
    Date of Patent: April 29, 2003
    Assignee: MetaMorphix, Inc.
    Inventor: Li-fang Liang
  • Patent number: 6368597
    Abstract: Methods for treating diabetes by administering an inhibitor of GDF-8, or a related member of Transforming Growth Factor-beta (TGF-&bgr;) superfamily of structurally-related growth factors (e.g., GDF-11) are disclosed. Also disclosed are methods for upregulating expression of hexose transporters, such as GLUT4 and GLUT1, in a subject by administering an inhibitor of GDF-8. Also disclosed are methods for increasing glucose uptake by cells in a subject, by administering an inhibitor of GDF-8.
    Type: Grant
    Filed: May 6, 1999
    Date of Patent: April 9, 2002
    Assignee: Matamorphix, Inc.
    Inventors: Gideon Strassmann, Li-fang Liang, Stavros Topouzis
  • Publication number: 20020031517
    Abstract: Methods for treating diabetes by administering an inhibitor of GDF-8, or a related member of Transforming Growth Factor-beta (TGF-&bgr;) superfamily of structurally-related growth factors (e.g., GDF-11) are disclosed. Also disclosed are methods for upregulating expression of hexose transporters, such as GLUT4 and GLUT1, in a subject by administering an inhibitor of GDF-8. Also disclosed are methods for increasing glucose uptake by cells in a subject, by administering an inhibitor of GDF-8.
    Type: Application
    Filed: November 19, 2001
    Publication date: March 14, 2002
    Inventors: Gideon Strassmann, Li-Fang Liang, Stavros Topouzis